Literature DB >> 19757090

Conformational analysis of thioglycoside derivatives of histo-blood group ABH antigens using an ab initio-derived reparameterization of MM4: implications for design of non-hydrolysable mimetics.

Francesco Strino1, Jenn-Huei Lii, Hans-Joachim Gabius, Per-Georg Nyholm.   

Abstract

Histo-blood group ABH antigens serve as recognition sites for infectious microorganisms and tissue lectins in intercellular communication, e.g. in tumor progression. Thus, they are of interest as a starting point for drug design. In this respect, potent non-hydrolysable derivatives such as thioglycosides are of special interest. As prerequisite to enable estimations of ligand properties relative to their natural counterparts, conformational properties of the thioglycosidic derivatives of ABH trisaccharides and their disaccharide units were calculated using systematic and filtered systematic searches with the MM4 force field. Parameters for the glycosidic torsions of thioglycosides were independently derived from ab initio calculations. The resulting energy deviations required a reparameterization of MM4 to a new parameter set called MM4R. The data sets obtained using MM4R reveal that the thioglycosides have somewhat increased levels of flexibility about the major low-energy conformations shared with the corresponding O-glycosides. In the trisaccharides, the thiosubstitution of the Gal[NAc]alpha1-3Gal linkage leads to a preference for a conformation which is the secondary minimum of the natural counterparts. This conformation also generates contacts between the N-acetyl group and the fucose moiety in the blood group A derivative. Calculations further indicate that thiosubstitution of only the Fucalpha1-2Gal linkage does not affect the conformational preferences compared to the natural trisaccharide. Thiosubstitution of both linkages in the trisaccharide results in increased flexibility but the favored conformation of the natural trisaccharides is preferred. The study suggests that thioglycoside derivatives of ABH antigens could have pharmaceutical interest as ligands of lectins and other carbohydrate-binding proteins.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19757090     DOI: 10.1007/s10822-009-9301-4

Source DB:  PubMed          Journal:  J Comput Aided Mol Des        ISSN: 0920-654X            Impact factor:   3.686


  24 in total

Review 1.  Eukaryotic glycosylation: whim of nature or multipurpose tool?

Authors:  G Reuter; H J Gabius
Journal:  Cell Mol Life Sci       Date:  1999-03       Impact factor: 9.261

2.  PCILO quantum-mechanical relaxed conformational energy map of methyl 4-thio-alpha-maltoside in solution.

Authors:  K Mazeau; I Tvaroska
Journal:  Carbohydr Res       Date:  1992-02-17       Impact factor: 2.104

3.  Glycosyldisulfides from dynamic combinatorial libraries as O-glycoside mimetics for plant and endogenous lectins: their reactivities in solid-phase and cell assays and conformational analysis by molecular dynamics simulations.

Authors:  Sabine André; Zhichao Pei; Hans-Christian Siebert; Olof Ramström; Hans-Joachim Gabius
Journal:  Bioorg Med Chem       Date:  2006-06-19       Impact factor: 3.641

Review 4.  Thio sugars: biological relevance as potential new therapeutics.

Authors:  Z J Witczak
Journal:  Curr Med Chem       Date:  1999-02       Impact factor: 4.530

5.  The use of a genetic algorithm search for molecular mechanics (MM3)-based conformational analysis of oligosaccharides.

Authors:  Abraham Nahmany; Francesco Strino; Jimmy Rosen; Graham J L Kemp; Per-Georg Nyholm
Journal:  Carbohydr Res       Date:  2005-04-11       Impact factor: 2.104

Review 6.  Histo-blood group antigen and human milk oligosaccharides: genetic polymorphism and risk of infectious diseases.

Authors:  Jacques Le Pendu
Journal:  Adv Exp Med Biol       Date:  2004       Impact factor: 2.622

7.  Alcohols, ethers, carbohydrates, and related compounds. III. The 1,2-dimethoxyethane system.

Authors:  Jenn-Huei Lii; Kuo-Hsiang Chen; T Bruce Grindley; Norman L Allinger
Journal:  J Comput Chem       Date:  2003-09       Impact factor: 3.376

8.  Correlation of expression of binding sites for synthetic blood group A-, B- and H-trisaccharides and for sarcolectin with survival of patients with bronchial carcinoma.

Authors:  K Kayser; N V Bovin; E Y Korchagina; C Zeilinger; F Y Zeng; H J Gabius
Journal:  Eur J Cancer       Date:  1994       Impact factor: 9.162

9.  The synthesis of a novel thio-linked disaccharide of chondroitin as a potential inhibitor of polysaccharide lyases.

Authors:  Carl S Rye; Stephen G Withers
Journal:  Carbohydr Res       Date:  2004-02-25       Impact factor: 2.104

Review 10.  Glycans: bioactive signals decoded by lectins.

Authors:  Hans-Joachim Gabius
Journal:  Biochem Soc Trans       Date:  2008-12       Impact factor: 5.407

View more
  4 in total

1.  Selenoglycosides in silico: ab initio-derived reparameterization of MM4, conformational analysis using histo-blood group ABH antigens and lectin docking as indication for potential of bioactivity.

Authors:  Francesco Strino; Jenn-Huei Lii; Chaitanya A K Koppisetty; Per-Georg Nyholm; Hans-Joachim Gabius
Journal:  J Comput Aided Mol Des       Date:  2010-10-26       Impact factor: 3.686

2.  Computational studies on the interaction of ABO-active saccharides with the norovirus VA387 capsid protein can explain experimental binding data.

Authors:  Chaitanya A K Koppisetty; Waqas Nasir; Francesco Strino; Gustaf E Rydell; Göran Larson; Per-Georg Nyholm
Journal:  J Comput Aided Mol Des       Date:  2010-04-21       Impact factor: 3.686

3.  Introducing 77Se NMR Spectroscopy to Analyzing Galectin -Ligand Interaction.

Authors:  Mária Raics; István Timári; László Szilágyi; Hans-Joachim Gabius; Katalin E Kövér
Journal:  Methods Mol Biol       Date:  2022

4.  Galectin-Glycan Interactions: Guidelines for Monitoring by 77 Se NMR Spectroscopy, and Solvent (H2 O/D2 O) Impact on Binding.

Authors:  Tammo Diercks; Francisco J Medrano; Forrest G FitzGerald; Donella Beckwith; Martin Jaeger Pedersen; Mark Reihill; Anna-Kristin Ludwig; Antonio Romero; Stefan Oscarson; Maré Cudic; Hans-Joachim Gabius
Journal:  Chemistry       Date:  2020-12-02       Impact factor: 5.236

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.